Notice: This company has been marked as potentially delisted and may not be actively trading. NYSE:GEN Genesis Healthcare (GEN) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipTrends About Genesis Healthcare Stock (NYSE:GEN) 30 days 90 days 365 days Advanced Chart Ad Stansberry Research25-Yr Wall St Legend: Get Out of Cash before Nov 6Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilson, an extremely rare window in the markets is about to open. It's an often-misunderstood market setup we've only seen 13 times since 1920. The last time this happened, it minted a million brand-new millionaires – in a single year. But Tilson says this unique window in the markets could close much sooner than anyone realizes, leaving most investors in the dust, while making a select few incredibly rich.Get our No. 1 stock (with 500%-plus upside potential) for this rare market event now. Key Stats Today's Range$26.98▼$27.4950-Day Range$0.18▼$0.6052-Week Range$0.40▼$1.37Volume1.80 million shsAverage Volume4.10 million shsMarket Capitalization$17.57 billionP/E Ratio30.54Dividend Yield1.82%Price Target$27.20Consensus RatingHold Company OverviewGenesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services; Rehabilitation Therapy Services; and Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy. In addition, the company offers other specialty medical services, such as physician, staffing, and other healthcare related services. As of December 31, 2020, it provided inpatient services through a network of approximately 341 skilled nursing facilities and assisted/senior living communities in 24 states; and supplied rehabilitation and respiratory therapy to approximately 1,400 healthcare locations in 42 states, the District of Columbia and China. The company was formerly known as FC-GEN Operations Investment, LLC and changed its name to Genesis HealthCare, Inc. in February 2015. Genesis HealthCare, Inc. was founded in 2003 and is headquartered in Kennett Square, Pennsylvania.Read More… 25-Yr Wall St Legend: Get Out of Cash before Nov 6 (Ad)Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilson, an extremely rare window in the markets is about to open. It's an often-misunderstood market setup we've only seen 13 times since 1920. The last time this happened, it minted a million brand-new millionaires – in a single year. But Tilson says this unique window in the markets could close much sooner than anyone realizes, leaving most investors in the dust, while making a select few incredibly rich.Get our No. 1 stock (with 500%-plus upside potential) for this rare market event now. Genesis Healthcare Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks24th Percentile Overall ScoreGEN MarketRank™: Genesis Healthcare scored higher than 24% of companies evaluated by MarketBeat, and ranked 307th out of 357 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.2 / 5Analyst RatingHold Consensus RatingGenesis Healthcare has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageGenesis Healthcare has only been the subject of 2 research reports in the past 90 days.Read more about Genesis Healthcare's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth5.52% Earnings GrowthEarnings for Genesis Healthcare are expected to grow by 5.52% in the coming year, from $1.63 to $1.72 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Genesis Healthcare is 30.54, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 129.01.Price to Earnings Ratio vs. SectorThe P/E ratio of Genesis Healthcare is 30.54, which means that it is trading at a less expensive P/E ratio than the Business Services sector average P/E ratio of about 38.81. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for GEN. Dividend2.5 / 5Dividend StrengthModerate Dividend YieldGenesis Healthcare pays a meaningful dividend of 3.05%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthGenesis Healthcare does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Genesis Healthcare is 55.56%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Genesis Healthcare will have a dividend payout ratio of 29.07% next year. This indicates that Genesis Healthcare will be able to sustain or increase its dividend.Read more about Genesis Healthcare's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for GEN. News and Social Media0.0 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 3 news articles for Genesis Healthcare this week, compared to 5 articles on an average week.Search InterestOnly 1 people have searched for GEN on MarketBeat in the last 30 days. This is a decrease of -90% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Genesis Healthcare to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Genesis Healthcare insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.30% of the stock of Genesis Healthcare is held by insiders.Percentage Held by Institutions82.08% of the stock of Genesis Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Genesis Healthcare's insider trading history. GEN Stock News HeadlinesBeyond Osteo or Joint Genesis: My Real Journey to Healthier Joints – Here’s What Helped MostOctober 4 at 7:51 PM | msn.comMercyOne Genesis, Davenport, announces new name, brandOctober 3, 2024 | yahoo.com25-Yr Wall St Legend: Get Out of Cash before Nov 6Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilson, an extremely rare window in the markets is about to open. It's an often-misunderstood market setup we've only seen 13 times since 1920. The last time this happened, it minted a million brand-new millionaires – in a single year. But Tilson says this unique window in the markets could close much sooner than anyone realizes, leaving most investors in the dust, while making a select few incredibly rich.October 7, 2024 | Stansberry Research (Ad)Genesis Health System is now MercyOne GenesisOctober 3, 2024 | msn.comPacific Smiles board set to reject Genesis’ $300m bidSeptember 29, 2024 | afr.comCareer Exploration Expo helped students connectSeptember 28, 2024 | yahoo.comJim de Bree | Troubling Agenda to Reform Health Care SystemSeptember 26, 2024 | msn.comNorton Benefit Solutions Expands Global OfferingSeptember 24, 2024 | prnewswire.comSee More Headlines GEN Stock Analysis - Frequently Asked Questions How were Genesis Healthcare's earnings last quarter? Genesis Healthcare, Inc. (NYSE:GEN) issued its quarterly earnings data on Thursday, August, 1st. The company reported $0.53 EPS for the quarter, meeting the consensus estimate of $0.53. Genesis Healthcare's revenue for the quarter was up 2.3% on a year-over-year basis. Is Genesis Healthcare doing a stock buyback? Genesis Healthcare's board approved a share buyback plan on Thursday, May 9th 2024, which permits the company to buy back $3,000,000,000 in outstanding shares, according to EventVestor. This means that the company could purchase up to 23.1% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company's board believes its shares are undervalued. Who are Genesis Healthcare's major shareholders? Genesis Healthcare's top institutional investors include Czech National Bank (0.02%), Czech National Bank (0.02%), Handelsbanken Fonder AB (0.02%) and SG Americas Securities LLC. View institutional ownership trends. What other stocks do shareholders of Genesis Healthcare own? Based on aggregate information from My MarketBeat watchlists, some other companies that Genesis Healthcare investors own include Flaherty & Crumrine Preferred Securities Income Fund (FFC), Vaxart (VXRT), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), AT&T (T), Amarin (AMRN) and Government Properties Income Trust (GOV). Company Calendar Last Earnings8/01/2024Ex-Dividend for 9/11 Dividend8/19/2024Dividend Payable9/11/2024Today10/07/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorBusiness Services Industry Prepackaged software Sub-IndustryN/A Current SymbolNYSE:GEN Previous SymbolNYSE:SKH CUSIPN/A CIK1351051 Webwww.genesishcc.com Phone610-444-6350Fax302-636-5454Employees2,700Year FoundedN/APrice Target and Rating Average Stock Price Target$27.20 High Stock Price Target$29.00 Low Stock Price Target$25.00 Potential Upside/Downside-1.1%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)$0.90 Trailing P/E Ratio30.54 Forward P/E Ratio16.87 P/E GrowthN/ANet Income$836 million Net Margins17.83% Pretax Margin23.69% Return on Equity155.48% Return on Assets9.12% Debt Debt-to-Equity Ratio7.50 Current Ratio0.48 Quick Ratio0.48 Sales & Book Value Annual Sales$2.80 billion Price / Sales6.28 Cash Flow$3.26 per share Price / Cash Flow8.42 Book Value($0.16) per share Price / Book-171.81Miscellaneous Outstanding Shares639,130,000Free Float618,038,000Market Cap$17.57 billion OptionableOptionable Beta0.84 This page (NYSE:GEN) was last updated on 10/7/2024 by MarketBeat.com Staff From Our PartnersCRUSHED: How Biden's Replacement Will Devastate Your 401(k)!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a ...Golden Crest | SponsoredBiden Deploys Phase 1 Fednow Digital CurrencyIf Kamala can steal the election…She'll steal your financial freedom next.American Alternative | SponsoredStrikes and Economic Unrest: Are You Prepared for What’s Coming?The rapid advancement of artificial intelligence and automation is reshaping industries and posing threats to ...InvestorPlace | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredNew President Kamala warningFinancial nightmare coming after election In 2018, one independent research predicted Kamala Harris was on ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Genesis Healthcare, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Genesis Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.